On Jun 29, 2018 Zogenix Inc (NASDAQ:ZGNX) Sellers Rose Their Shorts By 1.5%

June 29, 2018 - By Lena Young

Zogenix, Inc. (NASDAQ:ZGNX) Corporate Logo

Zogenix Inc (NASDAQ:ZGNX) had an increase of its short interest by 1.5%. In June was published ZGNX’s total 4.37M short interest by FINRA. The up change of 1.5% from 4.31 million shares was reported. Former ZGNX’s position will need 10 days to restore. It has 461,100 average volume. Zogenix Inc’s short interest float is 15.63%.

The stock increased 1.97% or $0.85 during the last trading session, reaching $44.1.Currently Zogenix, Inc. is uptrending after 225.58% change in last June 29, 2017. ZGNX has 402,807 shares volume. The stock outperformed the S&P500 by 213.01%.

Zogenix, Inc., a pharmaceutical company, develops and commercializes therapies for the treatment of central nervous system disorders in the United States.The firm is valued at $1.55 billion. The companyÂ’s lead product candidate is the ZX008, a low-dose fenfluramine, which is in Phase III clinical trials for the treatment of seizures associated with Dravet syndrome.Last it reported negative earnings. It also develops Relday, an injectable formulation of risperidone to treat the symptoms of schizophrenia and bipolar disorder in adults and teenagers with 13 years of age and older.

There’s a significant Zogenix, Inc. (NASDAQ:ZGNX) news published by Investorplace.com. It’s an article titled: “Here’s the Reason that GWPH Stock Tumbled Despite Regulatory Victory” on June 27, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.